Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, FR0010609263, PEA-PME eligible), leader in the field of optical biopsy, today announced the completion of its anticipated Board of Directors reorganization. At today’s Shareholder Meeting, Marie Meynadier and Jean-Luc Boulnois were elected to the Board of Directors replacing Creadev’s nominees the Board, Bertrand de Talhouët and Marie-Laure Pochon, who are leaving the Board following the recent sale of Creadev’s stake in the Company.
Help employers find you! Check out all the jobs and post your resume.
